Cargando…

Assessment of the Quality of Life for Gynecologic Cancer Patients Using Functional Assessment of Cancer Therapy-General (Fact-G) Questionnaire at Haji Adam Malik Hospital

BACKGROUND: Nowadays, successful treatment of cancer is not only measured by 5-years survival rate, but also by the patient’s quality of life (QOL). Delayed in the seeking of cancer treatment resulted in high morbidity and impact on the quality of life. AIM: This study aims to assess the QOL of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Edianto, Deri, Yaznil, Muhammad Rizki, Chartyansari, Ade Ayu, Effendi, Iman Helmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876803/
https://www.ncbi.nlm.nih.gov/pubmed/31777607
http://dx.doi.org/10.3889/oamjms.2019.391
Descripción
Sumario:BACKGROUND: Nowadays, successful treatment of cancer is not only measured by 5-years survival rate, but also by the patient’s quality of life (QOL). Delayed in the seeking of cancer treatment resulted in high morbidity and impact on the quality of life. AIM: This study aims to assess the QOL of patients with gynecologic cancer after therapy. The results of this research can be used as a basis for cancer treatment that should be holistic, not only to eradicate the disease, but also improve QOL. METHODS: A total of 47 respondents who went to the Department of Oncology, Haji Adam Malik Hospital Medan from May to October 2015 were asked to fill out the FACT-G questionnaire for the QOL assessment. The patient’s personal and disease data was taken from the medical records. The data were analysed statistically by one-way ANOVA test. RESULTS: The results showed that the physical, social, emotional and functional of cancer patients were not much different based on the variables studied. The QOL was higher in patients with endometrial cancer compared with other types of cancer. The QOL was also higher in patients who had completed treatment (> 6 months) and early-stages cancer. There was no statistical difference between the QOL of patients with gynecologic cancer based on therapeutic modalities, duration of treatment and the stage of disease (p > 0.05). CONCLUSION: This current study found the QOL, physical, and emotional complaints are still encountered.